Sex differences and clinical outcomes, including ventricular tachyarrhythmias, of patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan
Women with HFrEF treated with sacubitril/valsartan showed a greater improvement in LVEF compared to men, though clinical outcomes were similar across sexes. Female sex was not a predictor of ventricular tachyarrhythmias or mortality at 12 months.
Authors
- Tobias Schupp (ORCID: https://orcid.org/0000-0001-8171-7617)
- Michael Behnes (ORCID: https://orcid.org/0000-0001-5970-0093)
- Mohammad Abumayyaleh (ORCID: https://orcid.org/0000-0002-4766-5523)
- Christina Pilsinger
- Katherine Sattler
- İbrahim Akın (ORCID: https://orcid.org/0000-0003-1974-6147)
- Ibrahim El‐Battrawy (ORCID: https://orcid.org/0000-0002-0139-1045)
- Jonathan Demmer
- Carina Krack
- Nazha Hamdani
Institutions
- Ruhr University Bochum (DE)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3389/fcvm.2024.1503414
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.80